Table 2.
Frequency distributions of the analyzed VEGFR-2 gene polymorphisms in 78 Controls and 120 AMD patients.
| Controls | |||||
|---|---|---|---|---|---|
| Position | Genotype | n (%) | Allelic frequency n (%) | χ 2 | Hardy-Weinberg equilibrium |
| AA | 27 (34.62) | 89A (57.05) 67G (42.95) |
|||
| rs2071559 | AG | 35 (44.87) | χ 2 = 0.555 | P = 0.456 | |
| GG | 16 (20.51) | ||||
|
| |||||
| AA | 3 (3.85) | 31A (19.87) 125T (80.13) |
|||
| rs1870377 | AT | 25 (32.05) | χ 2 = 0.003 | P = 0.954 | |
| TT | 50 (64.10) | ||||
|
| |||||
| AMD patients | |||||
|
| |||||
| AA | 22 (18.33) | 107A (44.58) 133G (55.42) |
|||
| rs2071559 | AG | 63 (52.50) | χ 2 = 0.568 | P = 0.493 | |
| GG | 35 (29.17) | ||||
|
| |||||
| AA | 10 (8.33) | 63A (26.25) 177T (73.75) |
|||
| rs1870377 | AT | 43 (35.83) | χ 2 = 0.666 | P = 0.414 | |
| TT | 67 (55.84) | ||||